Regeneron's 'Champion Of Cancer Vaccines' Forges New Path

An Interview With Raquel Deering, Associate Director Of Immuno-Oncology At Regeneron

Raquel Deering, one of In Vivo's 2020 Rising Leaders, discusses Regeneron's efforts to develop combination therapies, its collaborations with cancer vaccine companies, and its plans to become a major force in the oncology field.

Magnifying lens over background with text Immuno-oncology, with the blurred lights visible in the background. 3D rendering.
• Source: Shutterstock

Raquel Deering knew she wanted to be a scientist as a young child. When she was 14, she called Paige Kaplan, a medical geneticist at The Children's Hospital of Philadelphia, and asked to visit to talk about her work. Kaplan agreed and was so impressed with Deering she took her on as an intern. For several years, Deering worked with a clinical fellow in a lab at the University of Pennsylvania and did clinical rounds with Kaplan at the hospital.

More from C-Suite Speaks

More from Leadership